Dr Reddys Laboratories Ltd Share Price Today - Live Blog for March 20, 2026

Dr Reddys Laboratories Ltd witnessed a substantial 1.95% increase in its share price and is currently trading at 1299.30. This remarkable performance has caught the eye of investors.

Dr Reddys Laboratories Ltd's shares saw an increase of 2.18%, reaching the current market price of 1302.30. This development underscores the stock's growing popularity.

In a noteworthy development, Dr Reddys Laboratories Ltd witnessed a remarkable 2.18% increase in its share price. This surge in value has sparked heightened investor interest, with the stock currently trading at 1302.30 per share. The stock has an ROE of 16.0277 and debt to equity ratio of 0.1625.

After a notable 1.88% increase, Dr Reddys Laboratories Ltd's shares are now trading at 1298.40. This surge signifies heightened investor interest in acquiring the stock. The stock has a debt to equity ratio of 0.1625 and an ROE of 16.0277.

Dr Reddys Laboratories Ltd observed a remarkable 1.88% surge in its share price and is presently trading at 1298.40. The increased investor interest is driving this surge.

Dr Reddys Laboratories Ltd witnessed a substantial 1.68% increase in its share price and is currently trading at 1295.90. This remarkable performance has caught the eye of investors.

Dr Reddys Laboratories Ltd observed a remarkable 1.68% surge in its share price and is presently trading at 1295.90. The increased investor interest is driving this surge.

Dr Reddys Laboratories Ltd's stock has risen by a substantial 1.54%, and as of now, it's trading at 1294.10 per share. This upward trajectory is attracting keen interest from investors.

Demonstrating a commendable 1.54% gain, Dr Reddys Laboratories Ltd's share price is currently situated at 1294.10. In terms of valuation, the stock maintains a PE ratio of 19.2500, while the industry PE ratio stands at 31.3241.

Dr Reddys Laboratories Ltd share price surged by 1.84%. With its current market price standing at 1298.00 per share, this stock is garnering increased attention from the investment community.

In a noteworthy development, Dr Reddys Laboratories Ltd witnessed a remarkable 1.84% increase in its share price. This surge in value has sparked heightened investor interest, with the stock currently trading at 1298.00 per share. The stock has an ROE of 16.0277 and debt to equity ratio of 0.1625.